p85β regulates autophagic degradation of AXL to activate oncogenic signaling
p85β (PIK3R2), a regulatory subunit of PI3K, has oncogenic properties. Here the authors show that p85β promotes AXL protein stability, which in turn activates p110 to induce PDK1/SGK3 signaling, and therapeutically, p85β-expressing ovarian cancer cells are sensitive to AXL inhibition.
Main Authors: | Ling Rao, Victor C. Y. Mak, Yuan Zhou, Dong Zhang, Xinran Li, Chloe C. Y. Fung, Rakesh Sharma, Chao Gu, Yiling Lu, George L. Tipoe, Annie N. Y. Cheung, Gordon B. Mills, Lydia W. T. Cheung |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16061-7 |
Similar Items
-
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
by: Xinran Li, et al.
Published: (2019-02-01) -
p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair
by: Victor CY Mak, et al.
Published: (2021-07-01) -
BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.
by: Ayaz Najafov, et al.
Published: (2018-08-01) -
The role of autophagic degradation in Cancer Treatment
by: Xiao-Feng Zhu
Published: (2017-03-01) -
Silencing of PARP2 Blocks Autophagic Degradation
by: Laura Jankó, et al.
Published: (2020-02-01)